One of the Best Ways to Trade Biotech

Biotech stocks are breaking higher. All thanks to the return of M&A.

Most recently, Bristol Myers agreed to acquire RayzeBio in a $4.1 billion deal, which is a 100% premium to its Friday closing price. “This transaction enhances our increasingly diversified oncology portfolio by bringing a differentiated platform and pipeline, and further strengthens our growth opportunities in the back half of the decade and beyond,” Bristol Myers Chief Executive Christopher Boerner said in a press release.

AstraZeneca also said it would buy Gracell in a deal worth $.1 billion. “The proposed acquisition of Gracell will complement AstraZeneca’s existing capabilities and previous investments in cell therapy, where we have established our presence in CAR-T and T-cell receptor therapies (TCR-Ts) in solid tumors,” said Susan Galbraith, executive VP of oncology R&D at AstraZeneca.

With many other major companies in desperate need of strengthening their pipelines, we could see many more deals just like these in the new year.  After all, according to, companies have about $1.34 trillion in cash on hand for acquisitions these days.

One of the best ways to gain exposure to even more M&A is with a biotech ETF, such as the iShares Biotechnology ETF (IBB). With an expense ratio of 0.45%, the ETF gives us access to 227 biotech companies at the moment, including Amgen, Gilead, Regeneron, Biogen, Moderna, Vertex, and Illumina to name a few of the top ones.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.